ALS breakthrough: Synapse-regenerating pill moves to phase 2 human trials
Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, affects nerve cells in the brain and spinal cord, called motor neurons, that control voluntary muscle movements like walking, talking, and breathing. As the neurons die and can’t send messages to the muscles, loss of muscle control worsens over time and is eventually fatal.
Tags: Neurological, Nerves, FDA
Comentarios
Publicar un comentario